Convergence Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.93M |
| 2 |
CACI
CACI
|
+$5.05M |
| 3 |
CELG
Celgene Corp
CELG
|
+$4.9M |
| 4 |
Yelp
YELP
|
+$4.72M |
| 5 |
Norfolk Southern
NSC
|
+$4.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradata
TDC
|
+$6.01M |
| 2 |
Gilead Sciences
GILD
|
+$5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.91M |
| 4 |
Copa Holdings
CPA
|
+$4.6M |
| 5 |
Lowe's Companies
LOW
|
+$4.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.19% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.55% |
| 4 | Industrials | 12.49% |
| 5 | Consumer Discretionary | 11.4% |
Similar funds
Convergence Investment Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Convergence Investment Partners held 1,093 positions worth $768M, up 3.1% from $745M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Convergence Investment Partners deployed $26.3M of net new capital in Q1 2018, opening 800 new positions and adding to 114 existing holdings. Its largest new stake was CACI: 34,563 shares worth $5.23M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Teradata, an estimated $6.01M trimmed.
- Convergence Investment Partners's largest Q1 2018 buy was CACI: 34,563 shares worth $5.23M.
- Convergence Investment Partners added most to Pfizer in Q1 2018, an estimated $5.93M increase.
- Convergence Investment Partners's biggest Q1 2018 reduction was Teradata, cutting an estimated $6.01M.
- Convergence Investment Partners fully exited Ingevity in Q1 2018, selling an estimated $3.95M.
- Convergence Investment Partners's ten largest holdings make up 13% of its $768M portfolio in Q1 2018.
- Convergence Investment Partners opened 800 new positions and closed 54 in Q1 2018.
- Convergence Investment Partners's portfolio value rose 3.1% quarter-over-quarter to $768M.
Based on Convergence Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.